tiprankstipranks
OncoZenge AB (DE:8LY)
FRANKFURT:8LY
Germany Market

OncoZenge AB (8LY) Financial Statements

0 Followers

OncoZenge AB Financial Overview

OncoZenge AB's market cap is currently ―. The company's EPS TTM is €-1.214; its P/E ratio is -0.26; OncoZenge AB is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Sep 21Jun 21Mar 21
Income Statement-
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr 0.00kr 0.00kr 0.00-kr 0.00
EBITkr -2.82Mkr -32.98Mkr -987.00Kkr -1.11Mkr -1.43M
EBITDAkr -2.82Mkr -9.82Mkr -987.00Kkr -1.11Mkr -1.43M
Net Income Common Stockholderskr -2.82Mkr -36.06Mkr -784.00Kkr -1.00Mkr -1.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 34.47Mkr 40.79Mkr 55.67Mkr 56.96Mkr 64.80M
Total Assetskr 43.24Mkr 48.76Mkr 83.88Mkr 83.58Mkr 96.77M
Total Debtkr 0.00kr 0.00kr 0.00kr 1.38Mkr 12.84M
Net Debtkr -34.47Mkr -40.79Mkr -55.67Mkr -55.58Mkr -51.95M
Total Liabilitieskr -1.02Mkr 4.50Mkr 2.47Mkr 1.38Mkr 12.84M
Stockholders Equitykr 44.26Mkr 44.26Mkr 81.41Mkr 82.20Mkr 83.92M
Cash Flow-
Free Cash Flowkr -6.32Mkr -10.43Mkr -1.29Mkr -3.47Mkr -916.00K
Operating Cash Flowkr -6.32Mkr -10.43Mkr 12.00Kkr -2.42Mkr -333.00K
Investing Cash Flowkr 0.00kr 0.00kr -1.30Mkr -1.05Mkr -583.00K
Financing Cash Flowkr 0.00kr 0.00kr 0.00kr -4.37Mkr 55.71M
Currency in SEK

OncoZenge AB Earnings and Revenue History

OncoZenge AB Debt to Assets

OncoZenge AB Cash Flow

OncoZenge AB Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis